With a commitment to building strategic partnerships and continuous research and development, Cynosure remains at the forefront of laser technology in medical aesthetics.

Laser technology has revolutionised the aesthetic industry in recent years, offering a range of treatments with exceptional results. As laser technology constantly evolves, with new advancements made over time, we will continue to see the introduction of more precise and effective treatments.

The future of laser technology in the aesthetic industry holds so much potential for even more advanced and customised treatments to cater to patients’ specific needs. As such, its benefits and growing popularity will ensure that lasers remain a major player in the aesthetic industry for years to come.

Amongst the many players, Cynosure Aesthetic and Medical APAC Services is at the forefront of the medical aesthetic industry, leading the way with Cynosure’s PicoSurePro, the first and only 755nm picosecond laser FDA-cleared to treat Nevus of Ota, Nevus of Hori, and Melasma.

This game-changing device takes picosecond laser technology to unprecedented levels of performance, with enhancements that include adjustable fluence, 50% more power, turbo mode for hard-to-treat areas, and the Platinum Focus lens that provides 40% more shots.

The PicosurePro technology delivers a more effective solution than traditional lasers. Due to its significant upgrades, practitioners are able to treat a wider variety of indications with greater versatility, to achieve better patient outcomes in less time. 

As laser technology continues to hold its place and evolve in the medical aesthetic industry, Cynosure is optimistic that there will be more advanced lasers that will be developed in the future to provide better results and improve patient outcomes.

In recognition of the innovation behind the development of PicosurePro, Cynosure Aesthetic and Medical APAC Services was awarded the ‘Healthcare Technology’ and ‘Machine – Healthcare Technology’ awards at the SBR International Business Awards and SBR Technology Excellence Awards, respectively.

“We are honoured to receive two awards for PicoSurePro in the Healthcare Technology category, demonstrating our commitment to making a positive impact for our customers and their patients,” said Bebe Teo Ai Choo, SVP Asia-Pacific and Commercial Excellence, International at Cynosure Aesthetic and Medical APAC Services.

Building strategic relationships and continuous R&D

Just like any other company in the healthcare technology industry, Cynosure also faces numerous challenges and obstacles in deploying solutions. Some of these challenges include navigating the complex and highly regulated hurdles to bring products to market and staying ahead of competitors who offer similar products and services.

With these challenges in mind, Cynosure is committed to building strategic partnerships with healthcare providers and industry stakeholders. This is to ensure that its healthcare technology solutions are effective, safe, and meet the evolving needs of patients and professional users.

These partnerships go hand in hand with innovation through clinically proven research and product development, conducted in collaboration with advisory board members, and through clinical studies, and customer feedback.

These R&D efforts can help identify new opportunities and address challenges in offering the highest level of efficacy and quality care to patients.

Adapting to the evolving industry landscape

Cynosure is amongst the leading companies in the medical aesthetic industry, and its focus on continued innovation underscores its commitment to staying ahead.

To achieve long-term success in the market, Cynosure reiterates its commitment to delivering innovative energy-based devices for medical aesthetics and health. It prioritises evidence-based medicine and clinical research to ensure the safety and efficacy of its solutions. 

At the same time, it adapts to the evolving healthcare technology landscape in three core areas: patient comfort by offering non-invasive and non-surgical treatment options, state-of-the-art devices enabling practitioners to introduce cutting-edge treatments as an attractive option for consumers, and increased return on investment by providing results based on science and built on trust with patients.

To remain at the forefront of the rapidly evolving healthcare technology landscape, Cynosure stays up-to-date with market trends and regulatory requirements whilst continuing to prioritise patient care, help practitioners grow their practices, and achieve optimal patient outcomes through clinically proven solutions.

The company is likely to continue to explore more such opportunities to improve the delivery and outcomes of healthcare through technology.

The SBR Technology Excellence Awards is presented by Singapore Business Review Magazine. To view the full list of winners, see here: https://tinhillpr.us13.list-manage.com/track/click?u=d6d55203ef952dc4f00474b03&id=84d0e87434&e=d1aec20673. If you want to join the 2024 awards programme and be acclaimed for your company’s outstanding contributions in pursuit of technological innovation, please contact Jane Patiag at jane@charltonmediamail.com.

Liked this post? Follow SwirlingOverCoffee on Facebook, YouTube, and Instagram.